| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.05 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.05 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.067 | 0.05 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.05 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.05 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.058 | 0.07 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.067 | 0.07 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.056 | 0.07 |